Adaptimmune Therapeutics shares owned by Renaissance Technologies
Quarter-by-quarter ownership of Adaptimmune Therapeutics (ADAP) shares owned by Renaissance Technologies
from 13F filings
Historical chart of Renaissance Technologies investment in Adaptimmune Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Adaptimmune Therapeutics held by Renaissance Technologies consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Adaptimmune Therapeutics by Renaissance Technologies
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $1.6M | 1.7M | 0.95 |
| 2024-06-30 | $1.7M | 1.8M | 0.97 |
| 2024-03-31 | $2.2M | 1.4M | 1.58 |
| 2023-12-31 | $1.1M | 1.4M | 0.79 |
| 2023-09-30 | $802k | 1.0M | 0.78 |
| 2023-06-30 | $1.4M | 1.5M | 0.92 |
| 2023-03-31 | $199k | 183k | 1.09 |
| 2022-12-31 | $819k | 561k | 1.46 |
| 2022-09-30 | $609k | 566k | 1.08 |
| 2022-06-30 | $867k | 510k | 1.70 |
| 2022-03-31 | $2.0M | 960k | 2.06 |
| 2021-12-31 | $1.6M | 428k | 3.75 |
| 2021-06-30 | $1.3M | 304k | 4.26 |
| 2021-03-31 | $536k | 101k | 5.31 |
| 2020-12-31 | $4.8M | 892k | 5.39 |
| 2020-09-30 | $11M | 1.3M | 7.98 |
| 2020-06-30 | $17M | 1.7M | 10.01 |
| 2020-03-31 | $4.8M | 1.7M | 2.72 |
| 2019-12-31 | $1.8M | 1.5M | 1.20 |
| 2019-09-30 | $1.3M | 879k | 1.51 |
| 2019-06-30 | $2.0M | 497k | 4.02 |
| 2019-03-31 | $3.4M | 795k | 4.30 |
| 2018-12-31 | $3.6M | 626k | 5.75 |
| 2018-09-30 | $14M | 1.0M | 13.56 |
| 2018-06-30 | $16M | 1.3M | 11.87 |
| 2018-03-31 | $15M | 1.3M | 11.23 |
| 2017-12-31 | $6.6M | 994k | 6.68 |
| 2017-09-30 | $9.5M | 1.2M | 8.19 |
| 2017-06-30 | $4.8M | 1.1M | 4.49 |
| 2017-03-31 | $4.3M | 781k | 5.51 |
| 2016-12-31 | $1.8M | 445k | 4.05 |
| 2016-09-30 | $2.3M | 329k | 7.05 |
| 2016-06-30 | $1.5M | 189k | 8.15 |
| 2016-03-31 | $920k | 113k | 8.13 |
| 2015-12-31 | $353k | 29k | 12.05 |